1. Home
  2. BBW vs AQST Comparison

BBW vs AQST Comparison

Compare BBW & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBW
  • AQST
  • Stock Information
  • Founded
  • BBW 1997
  • AQST 2004
  • Country
  • BBW United States
  • AQST United States
  • Employees
  • BBW N/A
  • AQST N/A
  • Industry
  • BBW Recreational Games/Products/Toys
  • AQST Biotechnology: Pharmaceutical Preparations
  • Sector
  • BBW Consumer Discretionary
  • AQST Health Care
  • Exchange
  • BBW Nasdaq
  • AQST Nasdaq
  • Market Cap
  • BBW 786.9M
  • AQST 809.3M
  • IPO Year
  • BBW 2004
  • AQST 2018
  • Fundamental
  • Price
  • BBW $56.06
  • AQST $6.72
  • Analyst Decision
  • BBW Strong Buy
  • AQST Strong Buy
  • Analyst Count
  • BBW 5
  • AQST 6
  • Target Price
  • BBW $68.80
  • AQST $10.33
  • AVG Volume (30 Days)
  • BBW 354.8K
  • AQST 3.0M
  • Earning Date
  • BBW 12-04-2025
  • AQST 11-05-2025
  • Dividend Yield
  • BBW 1.57%
  • AQST N/A
  • EPS Growth
  • BBW 25.62
  • AQST N/A
  • EPS
  • BBW 4.47
  • AQST N/A
  • Revenue
  • BBW $522,518,000.00
  • AQST $44,132,000.00
  • Revenue This Year
  • BBW $8.36
  • AQST N/A
  • Revenue Next Year
  • BBW $3.62
  • AQST $51.39
  • P/E Ratio
  • BBW $12.55
  • AQST N/A
  • Revenue Growth
  • BBW 8.10
  • AQST N/A
  • 52 Week Low
  • BBW $32.55
  • AQST $2.12
  • 52 Week High
  • BBW $75.85
  • AQST $7.55
  • Technical
  • Relative Strength Index (RSI)
  • BBW 38.91
  • AQST 56.39
  • Support Level
  • BBW $54.76
  • AQST $6.63
  • Resistance Level
  • BBW $58.40
  • AQST $7.18
  • Average True Range (ATR)
  • BBW 2.12
  • AQST 0.40
  • MACD
  • BBW -0.32
  • AQST -0.07
  • Stochastic Oscillator
  • BBW 16.24
  • AQST 31.69

About BBW Build-A-Bear Workshop Inc.

Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: